Evidence map›Paper›PMID 23349646›Full record

ArticleFrontiers in psychology2012

Cognitive and neuroplasticity mechanisms by which congenital or early blindness may confer a protective effect against schizophrenia.

Steven M Silverstein, Yushi Wang, Brian P Keane

Open access · goldAbstract read
In one paragraph

Article in Frontiers in psychology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Eyes, the window on psychosis?BJPsych open · 2022
    Article
  7. Article
  8. Article
  9. Oculomics in Schizophrenia Research.Schizophrenia bulletin · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Autism and psychosis as diametrical disorders of embodiment.Evolution, medicine, and public health · 2019
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Steven M SilversteinUniversity Behavioral HealthCare, University of Medicine and Dentistry of New Jersey Piscataway, NJ, USA ; Department of Psychiatry, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School Piscataway, NJ, USA.
Yushi Wang
Brian P Keane
Environmental and Occupational Health Sciences Institute · US

Funding

Perceptual Organization Dysfunction as a Biomarker of SchizophreniaR01MH093439 · NIMH · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI SILVERSTEIN, STEVEN M · 2011 to 2015
$2.1M
Spatial frequency contributions to contour integration deficits in schizophreniaF32MH094102 · NIMH · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI KEANE, BRIAN PATRICK · 2011 to 2014
$163k
NIMH NIH HHS F32 MH094102NIMH NIH HHS R01 MH093439
6 · The paper itself

Abstract

Several authors have noted that there are no reported cases of people with schizophrenia who were born blind or who developed blindness shortly after birth, suggesting that congenital or early (C/E) blindness may serve as a protective factor against schizophrenia. By what mechanisms might this effect operate? Here, we hypothesize that C/E blindness offers protection by strengthening cognitive functions whose impairment characterizes schizophrenia, and by constraining cognitive processes that exhibit excessive flexibility in schizophrenia. After briefly summarizing evidence that schizophrenia is fundamentally a cognitive disorder, we review areas of perceptual and cognitive function that are both impaired in the illness and augmented in C/E blindness, as compared to healthy sighted individuals. We next discuss: (1) the role of neuroplasticity in driving these cognitive changes in C/E blindness; (2) evidence that C/E blindness does not confer protective effects against other mental disorders; and (3) evidence that other forms of C/E sensory loss (e.g., deafness) do not reduce the risk of schizophrenia. We conclude by discussing implications of these data for designing cognitive training interventions to reduce schizophrenia-related cognitive impairment, and perhaps to reduce the likelihood of the development of the disorder itself.

Indexed as

blindnesscognitionperceptionplasticityschizophreniavisionvision disorders

Identifiers

PMID23349646
PMCPMC3552473
OpenAlexW2157081289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.